Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ceci

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Urology Oncology|June 17, 2022
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysisTatsushi Kawada, Takafumi Yanagisawa, Pawel Rajwa, et al.
Cancers|April 13, 2023
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage TreatmentLorenzo Bianchi, Francesco Ceci, Eleonora Balestrazzi, et al.
Blood Advances|February 22, 2023
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCLSaveria Mazzara, Laura Travaini, Francesca Botta, et al.
Cancers|January 8, 2023
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or RecurrenceLorenzo Bianchi, Francesco Ceci, Francesco Costa, et al.
European Urology Oncology|September 16, 2020
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic ReviewGiancarlo Marra, Massimo Valerio, Isabel Heidegger, et al.
Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2017
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesionsStefano Fanti, Silvia Minozzi, Joshua James Morigi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 2024
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysisGiulia Corrao, Giulia Marvaso, Federico Mastroleo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy PlanningJeremie Calais, Johannes Czernin, Minsong Cao, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Urology Oncology|June 17, 2022
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysisTatsushi Kawada, Takafumi Yanagisawa, Pawel Rajwa, et al.
Cancers|April 13, 2023
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage TreatmentLorenzo Bianchi, Francesco Ceci, Eleonora Balestrazzi, et al.
Blood Advances|February 22, 2023
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCLSaveria Mazzara, Laura Travaini, Francesca Botta, et al.
Cancers|January 8, 2023
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or RecurrenceLorenzo Bianchi, Francesco Ceci, Francesco Costa, et al.
European Urology Oncology|September 16, 2020
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic ReviewGiancarlo Marra, Massimo Valerio, Isabel Heidegger, et al.
Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2017
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesionsStefano Fanti, Silvia Minozzi, Joshua James Morigi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 2024
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysisGiulia Corrao, Giulia Marvaso, Federico Mastroleo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy PlanningJeremie Calais, Johannes Czernin, Minsong Cao, et al.
Pageof 15